MoneyWorks4Me

Nectar Lifesciences - Quaterly Results

15 May 2024 Evaluate
The revenue for the March 2024 quarter is pegged at Rs. 4413.75 millions, about 13.52% up against Rs. 3888.14 millions recorded during the year-ago period.The company reported a drastic decline of -88.81% in the quarter ended March 2024 to Rs. 6.00  millions from Rs. 53.63 millions  .Operating profit surged to 499.80 millions from the corresponding previous quarter of 376.96 millions.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202403 202303 % Var 202403 202303 % Var 202403 202303 % Var
Sales 4413.75 3888.14 13.52 16856.32 15246.09 10.56 16856.32 15246.09 10.56
Other Income 14.68 179.25 -91.81 130.30 422.39 -69.15 130.30 422.39 -69.15
PBIDT 499.80 376.96 32.59 1661.35 979.02 69.70 1661.35 979.02 69.70
Interest 241.60 196.58 22.90 871.42 794.76 9.65 871.42 794.76 9.65
PBDT 258.20 180.38 43.14 789.93 184.26 328.70 789.93 184.26 328.70
Depreciation 147.00 148.49 -1.00 607.18 591.19 2.70 607.18 591.19 2.70
PBT 111.20 31.89 248.70 182.75 -406.93 -144.91 182.75 -406.93 -144.91
TAX 105.20 -21.74 -583.90 132.74 -182.37 -172.79 132.74 -182.37 -172.79
Deferred Tax 105.20 -21.74 -583.90 132.74 -182.37 -172.79 132.74 -182.37 -172.79
PAT 6.00 53.63 -88.81 50.01 -224.56 -122.27 50.01 -224.56 -122.27
Equity 224.26 224.26 0.00 224.26 224.26 0.00 224.26 224.26 0.00
PBIDTM(%) 9.74 8.43 15.47 8.62 5.60 53.86 8.62 5.60 53.86
Peers
Company Name CMP
Sun Pharma. Inds. 1844.00
Dr. Reddys Labs. 1212.00
Cipla 1381.00
Lupin 2120.10
Zydus Lifesciences 1161.00
View more..